Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2025-12-24 @ 6:51 PM
NCT ID: NCT01080157
Eligibility Criteria: Inclusion Criteria: 1. Age greater than or equal to 45 years; OR 2. Age 18 to 44 years and a BMI \> 25 kg/m² with one or more of the following risk factors: * Elevated waist circumference, \> 35 inches for women and \>40 inches for men * Habitually physically inactive (does not exercise regularly) * Has a first-degree relative with diabetes * African American, Latino, Native American, Asian American, Pacific Islander * Has delivered a baby weighing \> 9 lb or diagnosed with gestational diabetes * Hypertension (≥130/≥ 85 mmHg) or being treated for hypertension * HDL cholesterol level \< 35 mg/dL and/or a fasting triglyceride level ≥ 250 mg/dL or being treated for dyslipidemia with medication * Has been previously diagnosed with Polycystic Ovary Syndrome (PCOS) * Had impaired glucose tolerance or impaired fasting glucose on previous testing within the last 3 yrs * Conditions associated with insulin resistance such as acanthosis nigricans * History of vascular disease including heart attack, stroke, angina, coronary heart disease, atherosclerosis, congestive heart failure or peripheral arterial disease Exclusion Criteria: * Prior participation in VL-2701 * Receiving investigational treatments in the past 14 days * Psychosocial issues that interfere with an ability to follow study procedures * Conditions that cause secondary diabetes including Cushing's syndrome, acromegaly, hemochromatosis, pancreatitis, or cystic fibrosis * Diagnosed with any type of diabetes, including type 1 or 2 * Taking glucose lowering medications * Known to be pregnant * Receiving dialysis or having known renal compromise * Scars, tattoos, rashes or other disruption/discoloration on the left volar forearm. * Recent (within past month) or current oral steroid therapy or topical steroids applied to the left forearm; inhaled steroid therapy is not excluded Current chemotherapy, or chemotherapy within the past 12 months * Receiving medications that fluoresce * Known to have, or at risk for, photosensitivity reactions ( e.g., sensitive to ultraviolet light, or taking medication known to cause photosensitivity) * Prior bariatric surgery
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Study: NCT01080157
Study Brief:
Protocol Section: NCT01080157